Search
for
Sort by
Research 61–90 of 1000+
- Safety of dermatologic medications in pregnancy and lactation
- Drug-Induced Hair Disorders
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients
- Pharmacological Treatment of Alopecia
- Lichen Planopilaris: The Alopecia We Cannot Overlook
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Hair loss and its management in children
- Secondary cicatricial and other permanent alopecias
- Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features
- Erosive pustular dermatosis of the scalp: causes and treatments
- An Update on Scalp Psoriasis
- Chemotherapy and Cutaneous Drug Reactions
- Lipid nanocarriers as innovative strategies for hair regrowth
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Generalized Pustular Psoriasis
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- A Classic Presentation of Acne Keloidalis Nuchae in a Black Male
- Case Report: The First Reported Case of Bullous Lichen Planus-Systemic Lupus Erythematosus Overlap Syndrome
- Alopecia areata
- The treatment of alopecia areata
- Primary cicatricial alopecia
- Immunomodulators in the treatment of cutaneous lymphoma
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report